DeutschNewstral
Article
BBC on 2015-09-29 04:13
Drug for early breast cancer licensed
Related news
- Breast cancer drug 'too costly' for NHSBBC
First breast cancer drug in decade approved for NHS useShropshire Star- BNHS reaches deal for life-saving breast-cancer drugbbc.co.uk
- Women 'denied cheap breast cancer drug'BBC
- NICE rejects breast cancer drug KadcylaBBC
U.K. Approves ‘Vital’ Breast Cancer Prevention DrugForbes
Miracle life-extending breast cancer drug approved for NHS after Daily Record campaignThe Daily Record
Socialised Medicine: Life-Prolonging Drug Deemed 'Too Expensive' for NHS Breast Cancer Patientsbreitbart.com- Breast cancer drug rejected for NHS despite doubling destruction of tumoursShropshire Star
Talks sought as 'important' new breast cancer drug not approved for NHS useexpressandstar.com
NHS accused of denying women lifesaving breast cancer drugtheweek.co.uk- Breast cancer drug licensed for women in early stage of diseaseexpressandstar.com
- FNHS watchdog blocks breast cancer drug in Englandft.com
United Kingdom’s National Institute for Health and Care Excellence (NICE) Recommends NanoString’s Prosigna Breast Cancer Gene Signature Assay to Guide Chemotherapy Treatment Decisions for Qualified Early-Stage Invasive Breast Cancer Patientscapitolhilltimes.com
Shorter drug treatment OK for many breast cancer patientsThe Findlay Courier